Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Sex difference in antithrombotic effect of aspirin.

Spranger M, Aspey BS, Harrison MJ.

Stroke. 1989 Jan;20(1):34-7.

2.

24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.

Würtz M, Hvas AM, Jensen LO, Kaltoft AK, Tilsted HH, Kristensen SD, Grove EL.

Int J Cardiol. 2014 Aug 1;175(2):274-9. doi: 10.1016/j.ijcard.2014.05.013. Epub 2014 May 16.

PMID:
24861258
3.

Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.

Bauriedel G, Skowasch D, Schneider M, Andrié R, Jabs A, Lüderitz B.

Am Heart J. 2003 Feb;145(2):343-8.

PMID:
12595854
4.

Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.

Würtz M, Grove EL, Wulff LN, Kaltoft AK, Tilsted HH, Jensen LO, Hvas AM, Kristensen SD.

JACC Cardiovasc Interv. 2010 Aug;3(8):828-35. doi: 10.1016/j.jcin.2010.05.014.

5.

A sex difference in the effect of aspirin on "spontaneous" platelet aggregation in whole blood.

Harrison MJ, Weisblatt E.

Thromb Haemost. 1983 Dec 30;50(4):773-4.

PMID:
6665757
6.
7.

Oral verapamil inhibits platelet thrombus formation in humans.

L-Lacoste L, Lam JY, Hung J, Waters D.

Circulation. 1994 Feb;89(2):630-4.

PMID:
8313551
8.

Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.

Hosokawa K, Ohnishi T, Sameshima H, Miura N, Ito T, Koide T, Maruyama I.

Thromb Haemost. 2013 Jan;109(1):102-11. doi: 10.1160/TH12-06-0441. Epub 2012 Nov 22.

PMID:
23179055
9.

[Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].

Skowasch D, Lentini S, Andrié R, Jabs A, Bauriedel G.

Dtsch Med Wochenschr. 2001 Jun 15;126(24):707-11. German.

PMID:
11446026
10.

Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Feher G, Koltai K, Papp E, Alkonyi B, Solyom A, Kenyeres P, Kesmarky G, Czopf L, Toth K.

Drugs Aging. 2006;23(7):559-67.

PMID:
16930084
11.

The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.

Can MM, Tanboğa IH, Türkyilmaz E, Karabay CY, Akgun T, Koca F, Tokgoz HC, Keles N, Ozkan A, Bezgin T, Ozveren O, Sonmez K, Sağlam M, Ozdemir N, Kaymaz C.

Thromb Res. 2010 Apr;125(4):e132-7. doi: 10.1016/j.thromres.2009.11.005. Epub 2009 Dec 1.

PMID:
19954823
12.

Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study).

Shen H, Herzog W, Drolet M, Pakyz R, Newcomer S, Sack P, Karon H, Ryan KA, Zhao Y, Shi X, Mitchell BD, Shuldiner AR.

Am J Cardiol. 2009 Aug 15;104(4):606-12. doi: 10.1016/j.amjcard.2009.04.027. Epub 2009 Jun 21.

13.

Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.

Rollini F, Franchi F, Cho JR, Degroat C, Bhatti M, Ferrante E, Patel R, Darlington A, Tello-Montoliu A, Desai B, Ferreiro J, Muniz-Lozano A, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ.

J Cardiovasc Transl Res. 2014 Feb;7(1):53-63. doi: 10.1007/s12265-013-9535-3. Epub 2014 Jan 7.

PMID:
24395495
14.

Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.

Wong PC, Crain EJ, Watson CA, Wexler RR, Lam PY, Quan ML, Knabb RM.

J Thromb Thrombolysis. 2007 Aug;24(1):43-51. Epub 2007 Feb 24.

PMID:
17323133
15.

Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients.

Koltai K, Papp J, Kenyeres P, Feher G, Tibold A, Alexy T, Marton Z, Kesmarky G, Toth K.

Biorheology. 2014;51(2-3):197-206. doi: 10.3233/BIR-140661.

PMID:
24898335
16.

Effects of copper-aspirin complex on platelet aggregation and thrombosis in rabbits and mice.

Shen ZQ, Liang Y, Chen ZH, Liu WP, Duan L.

J Pharm Pharmacol. 1998 Nov;50(11):1275-9.

PMID:
9877314
17.

Aspirin inhibition of platelet deposition at angioplasty sites: demonstration by platelet scintigraphy.

Cunningham DA, Kumar B, Siegel BA, Gilula LA, Totty WG, Welch MJ.

Radiology. 1984 May;151(2):487-90.

PMID:
6231656
18.

The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.

Norris LA, Devitt M, Bonnar J.

Thromb Res. 1996 Feb 15;81(4):407-17.

PMID:
8907290
19.

Danish very-low-dose aspirin after carotid endarterectomy trial.

Boysen G, Sørensen PS, Juhler M, Andersen AR, Boas J, Olsen JS, Joensen P.

Stroke. 1988 Oct;19(10):1211-5.

20.

Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.

Onoda K, Ohashi K, Hashimoto A, Okuda M, Shimono T, Nishikawa M, Shimpo H.

Ann Thorac Cardiovasc Surg. 2008 Aug;14(4):230-7.

PMID:
18818572

Supplemental Content

Support Center